Genetic alterations in ovarian borderline tumours and ovarian carcinomas

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 82, Issue 2, 1999, Pages 147-150

  Schuyer, M ^a   Henzen Logmans, S C ^a   Van Der Burg, M E L ^a   Fieret, J H ^a   Derksen, C ^a   Look, M P ^a   Meijer Van Gelder, M E ^a   Klijn, J G M ^a   Foekens, J A ^a   Berns, E M J J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; PROTEIN P53;

ADULT; AGED; CONFERENCE PAPER; FEMALE; GENE MUTATION; HEREDITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NONSENSE MUTATION; ONCOGENE K RAS; OVARY CARCINOMA; OVARY TUMOR; PRIORITY JOURNAL;

EID: 0032972776     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(98)00217-6     Document Type: Conference Paper

References (6)

1. Shelling A.N., Cooke I.E., Ganesan T.S. The genetic analysis of ovarian cancer. Br J Cancer. 72:1995;521-527.
2. ink4 ) gene alterations in human ovarian tumours. Br J Cancer. 74:1996;1069-1073.
3. Arg6Stop mutations of the TP53 gene in human ovarian cancer in the southwestern part of the Netherlands. Int J Cancer. 76:1998;299-303.
4. Mok S.C.H., Bell D.A., Knapp R.C., Fishbaugh P.M., Welch W.R., Muto M.G., Berkowitz R.S., Tsao S.W. Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res. 53:1993;1489-1492.
5. Teneriello M.G., Linnoila E.R.I., Nash M.H.J.D., Park R.C., Birrer M.J. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms. Cancer Res. 53:1993;3103-3108.
6. Ryan A., Al-Jehani R.M., Mulligan K.T., Jacobs I.J. No evidence exists for methylation inactivation of the p16 tumor suppressor gene in ovarian carcinogenesis. Gynecol Oncol. 68:1998;14-17.